Potential erosive effects of antihistamine containing syrup on primary teeth
African Journal of Medical and Health Sciences · 2014
DOI: 10.4103/2384-5589.139437 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Medical and Health Sciences, 2014. Verfasst von SheenAnn John und 2 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
The objective of this study was to evaluate the potential erosive effects of an antihistamine containing syrup on the primary teeth. Materials and Methods: In this study, 30 teeth samples were selected after stereomicroscopic assessment Out of these, 15 samples in the control group were subjected only to pH cycling and the other 15 samples in the experimental group were subjected to pH cycling and antihistamine exposure for 5 days. At the end of the cycle, all these samples were evaluated using the Atomic Force Microscope for surface roughness values.
Results
Independent t -test was used to evaluate the erosive effects of antihistamine containing drug on the primary surfaces. The mean difference in the surface roughness values between the control and experimental groups was found to be statistically highly significant.
Conclusion
To conclude, the antihistamine containing syrup Piriton ® was found to be erosive.
Zitieren
APA
John, S., Mallikarjun, S., & Rao, V. N. (2014). Potential erosive effects of antihistamine containing syrup on primary teeth. African Journal of Medical and Health Sciences. https://doi.org/10.4103/2384-5589.139437
Vancouver
John S, Mallikarjun S, Rao VN. Potential erosive effects of antihistamine containing syrup on primary teeth. African Journal of Medical and Health Sciences. 2014. doi:10.4103/2384-5589.139437
BibTeX
@article{John2014,
author = {John, SheenAnn and Mallikarjun, ShanthalaButhanahosur and Rao, VangaVenkata Narasimha},
title = {Potential erosive effects of antihistamine containing syrup on primary teeth},
journal = {African Journal of Medical and Health Sciences},
year = {2014},
doi = {10.4103/2384-5589.139437}
}
EUVIMED